Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: intraabdominal mass major surgical or invasive procedure: exploratory laparotomy, left lateral segmentectomy and splenectomy. history of present illness: 57f admitted last month for respiratory compensation, found to have abdominal mass incidentally on ct chest. she denied any abdominal pain, diarrhea, constipation, or recent weight loss. work-up at that time showed no evidence of metastasis. the origin of the mass was questionable, with mri suggestive of splenic origin and us suggestive of hepatic origin. it was decided that after her respiratory issues were resolved that she return to the hospital for exploratory laparotomy and resection of the mass. past medical history: dm, last a1c 7.7 in esrd (2o2 iddm and htn), s/p renal transplant on immunosuppressants, episode of allograft nephropathy documented by biopsy htn b/l thoracotomy for spontaneous ptx, hyperlipidemia lymphangiomeiomatosis (cystic dz) of lung social history: pt was raised in the phillipines, immigrated to the us in . married lives with husband. 2 kids. no tob/etoh/drugs. family history: nc physical exam: nad ctab rrr soft, nontender, obese no edema pertinent results: 05:00am blood wbc-10.9 rbc-2.66* hgb-7.7* hct-23.9* mcv-90 mch-29.1 mchc-32.4 rdw-16.0* plt ct-354 07:15pm blood wbc-3.5* rbc-3.91* hgb-10.3* hct-33.6* mcv-86 mch-26.4* mchc-30.8* rdw-15.9* plt ct-140* 05:00am blood plt ct-354 05:08am blood pt-11.4 ptt-30.1 inr(pt)-1.0 07:15pm blood pt-11.6 ptt-27.8 inr(pt)-1.0 05:00am blood glucose-140* urean-43* creat-3.6* na-143 k-3.4 cl-109* hco3-25 angap-12 07:15pm blood glucose-206* urean-86* creat-3.9* na-141 k-4.8 cl-111* hco3-17* angap-18 05:00am blood alt-15 ast-7 alkphos-57 amylase-28 totbili-0.1 07:15pm blood alt-12 ast-13 ld(ldh)-204 alkphos-83 amylase-62 totbili-0.1 05:00am blood albumin-2.6* calcium-7.9* phos-3.6 mg-1.6 cxr: overall unchanged appearance of the chest with cardiomegaly, increased interstitial markings with cystic changes, representing interstitial lung disease noted on the prior ct scan. small bilateral pleural effusion in bilateral costophrenic angles. ekg: sinus rhythm nonspecific lateral st-t wave abnormalities late precordial qrs transition - is nonspecific since previous tracing of , modest sinus tachycardia and st-t wave changes present rue us: 1. no deep venous thrombosis in right internal jugular, subclavian, axillary, basilic, or brachial veins. 2. unusual structure within the right antecubital fossa containing arterial waveform, possibly representing an av malformation. brief hospital course: 57f admitted for resection of intrabdominal mass. pt underwent splenectomy and left lateral segmentectomy on (see operative report for details) and was extubated and transferred to the pacu in stable condition. she remained in the icu overnight for monitoring. pain was controlled with pca and pt was started on sips and clears. she was transferred to the floor on pod1. she did have some respiratory issues post-operatively, requiring supplemental o2 via nasal cannula and face tent. cxr showed bilateral cystic disease consistent lam and prominent interstitial markings. she was diuresed with iv lasix, given chest pt, frequent neb treatments, and encouraged to use incentive spirometry. her diet was advanced on pod2. on pod4 pt had a fever of 101.9 and she was pan-cultured. she was also placed on vanc and levo for empiric coverage. she defervesced with improved respiratory status. she also became anemic with hct of 24.5 and was transfused 1 unit of prbc. pt was consulted and after many days of therapy, pt was cleared for discharge home. her jp amylase remained normal and her jp's were removed on pod5 and 6. by pod7, pt was tolerating a po diet, pain was well-controlled with po medication, and oxygen-requirements returnd to baseline. she was discharged on in stable condition. her immunosuppression and renal function was followed throughout her hospital course by transplant nephrology. medications on admission: 1. prednisone 5 mg tablet sig: one (1) tablet po daily (daily). 2. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po 3x/week (mo,we,fr). 3. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 5. metoprolol tartrate 50 mg tablet sig: two (2) tablet po bid (2 times a day). 6. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily). 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 8. sodium citrate-citric acid 500-334 mg/5 ml solution sig: thirty (30) ml po bid (2 times a day). 9. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). 10. doxazosin 1 mg tablet sig: one (1) tablet po bid (2 times a day). 11. calcitriol 0.5 mcg capsule sig: one (1) capsule po daily (daily). 12. rosuvastatin 5 mg tablet sig: one (1) tablet po daily (daily). 13. furosemide 40 mg tablet sig: one (1) tablet po bid (2 times a day). discharge medications: 1. prednisone 5 mg tablet sig: one (1) tablet po daily (daily). 2. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po 3x/week (mo,we,fr). 3. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 4. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. disp:*40 tablet(s)* refills:*0* 5. metoprolol tartrate 50 mg tablet sig: two (2) tablet po bid (2 times a day). 6. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily). 7. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 8. sodium citrate-citric acid 500-334 mg/5 ml solution sig: thirty (30) ml po bid (2 times a day). 9. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). 10. doxazosin 1 mg tablet sig: one (1) tablet po bid (2 times a day). 11. calcitriol 0.5 mcg capsule sig: one (1) capsule po daily (daily). 12. rosuvastatin 5 mg tablet sig: one (1) tablet po daily (daily). 13. furosemide 40 mg tablet sig: one (1) tablet po bid (2 times a day). 14. outpatient lab work biweekly labs (every monday and thursday): chem7, cbc, ca, po4, ast, t bili, u/a discharge disposition: home with service discharge diagnosis: left upper quadrant mass. discharge condition: good discharge instructions: -resume your regular medications. -take all new medications as directed. -do not drive while taking narcotics. -you may shower. allow water to run over the wound, but do not scrub. pat the wound dry. do not take a bath or swim until after follow-up appointment. no heavy lifting (> 10 lbs) for 6 weeks. please call your doctor or return to the er if you experience: -fever (> 101.4) -inability to eat/drink or persistent vomiting -increased pain -redness or discharge from your wound -other symptoms concerning to you followup instructions: , md phone: date/time: 3:20 , md phone: date/time: 11:10 procedure: total splenectomy transfusion of packed cells partial hepatectomy diagnoses: end stage renal disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease unspecified sleep apnea malignant neoplasm of liver, primary kidney replaced by transplant neoplasm of uncertain behavior of trachea, bronchus, and lung 

Answer: The patient is high likely exposed to